Next Big Innovation Labs is a deep tech 3D Bioprinting platform developing products and services using cutting edge 3D Bioprinting technology for R&D and Clinical applications. We strive to change the paradigm and challenge the current norms of regenerative medicine by developing breakthrough products that positively impact Animal Free R&D, Precision Medicine and Personalised Therapies. We, at NBIL, believe that disruptive inventions do not only come from one person but from a collaborative community. Since our inception in 2016, we have been working with multiple researchers across diverse domain to continuously explore the unending applications of 3D Bioprinting. The goal is to one day bridge the gap between global organ demand and availability.
Co-CEO | Co-Founder
Piyush is a Biotech graduate from VIT University and brings in his sales and marketing experience from Biocon and Roche, working in the Renal and Liver Transplantation segments. Piyush brings in his pharmaceutical experience to build products specific to the current market needs.